Naama Geva-Zatorsky is an Associate Professor and Head of the Department of Cell Biology and Cancer Sciences at Technion’s Rappaport Faculty of Medicine. She completed her Ph.D. with honors in Systems-Biology in Prof. Uri Alon’s lab at the Weizmann Institute, studying protein dynamics in cancer, and her postdoc in Prof. Dennis Kasper’s lab at Harvard Medical School, supported by Human Frontiers and EMBO fellowships and UNESCO-L’Oréal national and international awards. Her lab combines computational and experimental approaches in Systems-Biology, Microbiology and Immunology to study functional interactions of the microbiota with bacteriophages and the mammalian host, with a major focus on the microbiome in cancer and cancer therapy. Central to her work is microbial functional plasticity: how microbes reversibly alter their functions in response to their environment and bacteriophages. Her team uncovered such plasticity in inflammatory bowel disease and in response to diet, and is now investigating it in other physiologically relevant settings in health and disease. Honors include election to Israel Young National Academy of Science, Johnson&Johnson WISTEM2D and Alon awards, CIFAR Humans&Microbiome and US National Academy of Sciences Kavli Frontiers of Science fellowships, and ERC Starting and Israeli Science Foundation grants. She currently serves as President of the Israel Society for Microbiology.